Publisher： Bentham Science Publishers
E-ISSN： 1873-4316|17|10|856-865
ISSN： 1389-2010
Source： Current Pharmaceutical Biotechnology, Vol.17, Iss.10, 2016-08, pp. : 856-865
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies
Current Cancer Drug Targets, Vol. 16, Iss. 9, 2016-10 ,pp. :
Access to resources
Recommend
Drugs targeting integrins for cancer therapy
By Binder Mascha Trepel Martin
Expert Opinion on Drug Discovery, Vol. 4, Iss. 3, 2009-03 ,pp. :
Applying precision medicine to the active surveillance of prostate cancer
Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. :
Personalized Precision Medicine in Cancer: A Theranostic Approach
Current Radiopharmaceuticals, Vol. 10, Iss. 3, 2017-11 ,pp. :